Annual EBITDA
$122.50M$99.43M+430.97%
Summary
- Current Value
- As of today, EXAS annual EBITDA is $122.50M, up +430.97% on
- Historical Performance
- EXAS annual EBITDA is up +131.03% over the past 3 years, up +464.85% over the past 5 years
- All-Time High Comparison
- EXAS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXAS annual EBITDA is +131.03% above its 3-year low of -$394.72M reached on an earlier date
- Sector Comparison
- EXAS annual EBITDA is higher than 87.25% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $122.50M | +431.0% | +131.0% | +464.9% | +1156.4% | |
| Quarterly EBITDA | -$20.33M | -278.7% | +66.6% | -148.3% | -440.6% | |
| TTM EBITDA | $65.90M | +355.0% | +119.1% | +562.9% | +668.3% | |
| Price | $103.43 | +108.9% | +62.9% | -30.0% | +1753.6% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.25B | +17.7% | +55.8% | +117.7% | +10000.0% | |
| Annual EPS | -$1.10 | +80.3% | +68.8% | +79.8% | -280.0% | |
| $0.00 | +100.0% | +100.0% | +100.0% | +100.0% | ||
| Annual Net Income | -$207.95M | +79.8% | +66.7% | +74.8% | -1699.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $122.50M | at high | |
| 5Y | $122.50M | at high | |
| All | $122.50M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$394.72M | N/A | +131.0% |
| 5Y | -$523.04M | +123.4% | |
| All | -$523.04M | +123.4% |
EBITDA History
FAQ
What is the current annual EBITDA of EXAS?
As of today, EXAS annual EBITDA is $122.50M
What is 1-year change in EXAS annual EBITDA?
EXAS annual EBITDA is up +430.97% year-over-year
What is 3-year change in EXAS annual EBITDA?
EXAS annual EBITDA is up +131.03% over the past 3 years
How far is EXAS annual EBITDA from its all-time high?
EXAS annual EBITDA is currently at its all-time high
How does EXAS annual EBITDA rank versus sector peers?
EXAS annual EBITDA is higher than 87.25% of companies in Healthcare sector
When is EXAS next annual earnings release?
As of today, the next annual earnings release for EXAS has not been scheduled
Quarterly EBITDA
-$20.33M$92.49M-128.17%
Summary
- Current Value
- As of today, EXAS quarterly EBITDA is -$20.33M, down -128.17% on
- Historical Performance
- EXAS quarterly EBITDA is down -278.72% year-over-year, up +66.56% over the past 3 years
- All-Time High Comparison
- EXAS quarterly EBITDA is currently -128.17% below its historical high of $72.17M set on
- 3-Year Low Comparison
- EXAS quarterly EBITDA is +66.56% above its 3-year low of -$60.78M reached on an earlier date
- Sector Comparison
- EXAS quarterly EBITDA is higher than 20.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$20.33M | -128.2% | -278.7% | +66.6% | -148.3% | |
| Annual EBITDA | $122.50M | – | +431.0% | +131.0% | +464.9% | |
| TTM EBITDA | $65.90M | -32.5% | +355.0% | +119.1% | +562.9% | |
| Price | $103.43 | +2.7% | +108.9% | +62.9% | -30.0% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $878.38M | +3.3% | +23.1% | +58.8% | +88.4% | |
| Quarterly EPS | -$0.45 | -337.7% | +90.3% | +37.0% | +83.1% | |
| $0.00 | -100.0% | +100.0% | +100.0% | +100.0% | ||
| Quarterly Net Income | -$85.96M | -338.7% | +90.1% | +32.7% | +79.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $72.17M | -128.2% | |
| 3Y | $72.17M | -128.2% | |
| 5Y | $72.17M | -128.2% | |
| All | $72.17M | -128.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$43.99M | +53.8% | |
| 3Y | -$60.78M | N/A | +66.6% |
| 5Y | -$240.80M | +91.6% | |
| All | -$240.80M | +91.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of EXAS?
As of today, EXAS quarterly EBITDA is -$20.33M
What is EXAS quarterly EBITDA most recent change?
EXAS quarterly EBITDA was down -128.17% on December 31, 2025
What is 1-year change in EXAS quarterly EBITDA?
EXAS quarterly EBITDA is down -278.72% year-over-year
How far is EXAS quarterly EBITDA from its all-time high?
EXAS quarterly EBITDA is currently -128.17% below its historical high of $72.17M set on September 30, 2025
How does EXAS quarterly EBITDA rank versus sector peers?
EXAS quarterly EBITDA is higher than 20.91% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
TTM EBITDA
$65.90M$31.70M-32.48%
Summary
- Current Value
- As of today, EXAS TTM EBITDA is $65.90M, down -32.48% on
- Historical Performance
- EXAS TTM EBITDA is up +354.98% year-over-year, up +119.12% over the past 3 years
- All-Time High Comparison
- EXAS TTM EBITDA is currently -32.48% below its historical high of $97.60M set on
- 3-Year Low Comparison
- EXAS TTM EBITDA is +119.12% above its 3-year low of -$344.58M reached on an earlier date
- Sector Comparison
- EXAS TTM EBITDA is higher than 82.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $65.90M | -32.5% | +355.0% | +119.1% | +562.9% | |
| Annual EBITDA | $122.50M | – | +431.0% | +131.0% | +464.9% | |
| Quarterly EBITDA | -$20.33M | -128.2% | -278.7% | +66.6% | -148.3% | |
| Price | $103.43 | +2.7% | +108.9% | +62.9% | -30.0% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.25B | +5.3% | +17.7% | +55.8% | +117.7% | |
| TTM EPS | -$1.10 | +79.2% | +80.1% | +68.8% | +79.5% | |
| -$79.00M | +34.6% | +60.6% | +86.2% | +53.3% | ||
| TTM Net Income | -$207.95M | +78.9% | +79.8% | +66.7% | +74.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $97.60M | -32.5% | |
| 3Y | $97.60M | -32.5% | |
| 5Y | $97.60M | -32.5% | |
| All | $97.60M | -32.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.48M | N/A | +355.0% |
| 3Y | -$344.58M | N/A | +119.1% |
| 5Y | -$569.60M | +111.6% | |
| All | -$569.60M | +111.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of EXAS?
As of today, EXAS TTM EBITDA is $65.90M
What is EXAS TTM EBITDA most recent change?
EXAS TTM EBITDA was down -32.48% on December 31, 2025
What is 1-year change in EXAS TTM EBITDA?
EXAS TTM EBITDA is up +354.98% year-over-year
How far is EXAS TTM EBITDA from its all-time high?
EXAS TTM EBITDA is currently -32.48% below its historical high of $97.60M set on September 30, 2025
How does EXAS TTM EBITDA rank versus sector peers?
EXAS TTM EBITDA is higher than 82.47% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414026000011/0001124140-26-000011-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414026000011/0001124140-26-000011-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas